News
19m
Stockhead on MSNASX Quarterly Health Wrap: Island completes Phase 2a/b mosquito-borne dengue trialIsland Pharmaeuticals, Dimerix and Tryptamine Therapeutics are among ASX health stocks reporting quarterly results this week.
The Food and Drug Administration is attempting to phase out petroleum-based synthetic blue, red, yellow, green dyes in favor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results